BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10924384)

  • 1. MR appearance of metastatic melanotic melanoma in the breast.
    Ho LW; Wong KP; Chan JH; Chow LW; Leung EY; Leong L
    Clin Radiol; 2000 Jul; 55(7):572-3. PubMed ID: 10924384
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of metastatic melanoma to the heart with an intrinsic contrast approach using melanin inversion recovery imaging.
    Crean AM; Juli C
    J Comput Assist Tomogr; 2007; 31(6):924-30. PubMed ID: 18043358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A rare differential diagnosis of suspicious contrast medium enhancement in breast MRI. Melanoma metastasis in both breasts].
    Heinig A; Heywang-Köbrunner SH; Wohlrab J
    Radiologe; 1997 Jul; 37(7):588-90. PubMed ID: 9340693
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast magnetic resonance imaging: principles and techniques.
    Kaiser WA
    Semin Roentgenol; 2007 Oct; 42(4):228-35. PubMed ID: 17919525
    [No Abstract]   [Full Text] [Related]  

  • 5. The breast dynamic contrast enhanced MRI: preliminary results of a quantitative analysis.
    Di Nallo AM; Crecco M; Ortenzia O; Ordonez R; Abate A; Benassi M
    J Exp Clin Cancer Res; 2007 Jun; 26(2):235-9. PubMed ID: 17725104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of intraductal papillomas of the breast.
    Tominaga J; Hama H; Kimura N; Takahashi S
    J Comput Assist Tomogr; 2011; 35(1):153-7. PubMed ID: 21245701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic melanoma of the gallbladder.
    Takayama Y; Asayama Y; Yoshimitsu K; Irie H; Tajima T; Hirakawa M; Ishigami K; Kakihara D; Sugitani A; Moroi Y; Eguchi T; Honda H
    Comput Med Imaging Graph; 2007 Sep; 31(6):469-71. PubMed ID: 17517496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study.
    Onishi M; Furukawa A; Takahashi M; Murata K
    Eur J Radiol; 2008 Feb; 65(2):286-92. PubMed ID: 17683886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR-guided intervention in women with a family history of breast cancer.
    Viehweg P; Bernerth T; Kiechle M; Buchmann J; Heinig A; Koelbl H; Laniado M; Heywang-Köbrunner SH
    Eur J Radiol; 2006 Jan; 57(1):81-9. PubMed ID: 16364583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
    Hylton NM
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):321-32, vi. PubMed ID: 11493422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases.
    Kremer S; Grand S; Berger F; Hoffmann D; Pasquier B; Rémy C; Benabid AL; Bas JF
    Neuroradiology; 2003 Jan; 45(1):44-9. PubMed ID: 12525954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.
    Kurul S; Taş F; Büyükbabani N; Mudun A; Baykal C; Camlica H
    Jpn J Clin Oncol; 2005 Apr; 35(4):202-6. PubMed ID: 15845569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance findings in women at high risk for developing breast cancer: an Australian feasibility study.
    Peters G; Anderson J; Longman G; Thomson J; Taylor D; Bennett M; Wylie E; Goldblatt J; Chan A; Saunders C
    J Med Imaging Radiat Oncol; 2008 Feb; 52(1):29-35. PubMed ID: 18373823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR imaging of liver metastasis using Gd-EOB-DTPA].
    Kuwatsuru R
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1234-41. PubMed ID: 19692760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced breast MR imaging.
    Moon M; Cornfeld D; Weinreb J
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.